Monash Antibody Discovery Platform (MADP) provides services for antibody discovery, antibody production, antibody sequencing and cell line cryopreservation.  The primary focus in the core is generating high-affinity monoclonal antibodies that are specific for the customer’s needs but we also offer a range of services related to cell line work and antibody characterisation.

QUALITY: As part of the Monash Technology Research Platform Network, we are committed to providing excellence and quality through all stages of research, industry engagement and collaborations. To achieve this objective, we have implemented a platform quality management system that complies with the requirements of ISO 9001:2015 Quality Management System.